IRIS
PELAIA, GIROLAMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.008
AS - Asia 4.114
EU - Europa 1.686
SA - Sud America 1.142
Continente sconosciuto - Info sul continente non disponibili 265
AF - Africa 79
OC - Oceania 10
Totale 13.304
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.796
SG - Singapore 1.842
CN - Cina 934
BR - Brasile 878
IT - Italia 855
VN - Vietnam 497
IN - India 354
DE - Germania 191
GB - Regno Unito 168
HK - Hong Kong 166
SE - Svezia 143
CA - Canada 134
AR - Argentina 111
BD - Bangladesh 75
FI - Finlandia 72
EC - Ecuador 46
ID - Indonesia 45
MX - Messico 45
NL - Olanda 35
ES - Italia 32
FR - Francia 29
IQ - Iraq 29
RU - Federazione Russa 28
TR - Turchia 26
PY - Paraguay 23
VE - Venezuela 23
PL - Polonia 21
UA - Ucraina 21
JP - Giappone 19
ZA - Sudafrica 19
CL - Cile 17
CO - Colombia 16
PE - Perù 16
PK - Pakistan 16
MA - Marocco 14
CZ - Repubblica Ceca 13
DO - Repubblica Dominicana 13
EG - Egitto 13
IE - Irlanda 13
TW - Taiwan 13
UZ - Uzbekistan 11
SA - Arabia Saudita 10
AT - Austria 9
AU - Australia 9
IL - Israele 9
UY - Uruguay 9
LT - Lituania 8
RO - Romania 8
DZ - Algeria 7
KE - Kenya 7
LB - Libano 7
JO - Giordania 6
MY - Malesia 6
NP - Nepal 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
EU - Europa 5
IR - Iran 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
CH - Svizzera 4
CR - Costa Rica 4
DK - Danimarca 4
KZ - Kazakistan 4
PT - Portogallo 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
AZ - Azerbaigian 3
BN - Brunei Darussalam 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
KR - Corea 3
LV - Lettonia 3
OM - Oman 3
PH - Filippine 3
PR - Porto Rico 3
SV - El Salvador 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
BE - Belgio 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
GY - Guiana 1
JM - Giamaica 1
KW - Kuwait 1
Totale 13.038
Salva come PNG Salva come JPEG
Città #
San Jose 1.159
Singapore 604
Chandler 574
Ashburn 501
Dallas 372
Santa Clara 333
Bengaluru 288
Hefei 288
Council Bluffs 254
Milan 252
Lawrence 227
Princeton 227
Ho Chi Minh City 199
Hong Kong 161
Beijing 152
Wilmington 144
Chicago 119
London 118
Munich 117
Hanoi 98
Ottawa 91
São Paulo 82
Catanzaro 73
Des Moines 71
Turku 51
Boardman 49
Los Angeles 43
New York 43
Naples 35
Rome 35
Shanghai 31
Da Nang 26
Rio de Janeiro 26
Phoenix 23
San Francisco 23
Brooklyn 22
Quito 22
Haiphong 21
Mexico City 21
Palermo 21
Warsaw 21
Atlanta 19
Florence 19
Guangzhou 19
Redwood City 19
Seattle 19
Boston 18
Helsinki 18
Norwalk 18
The Dalles 18
Buenos Aires 17
Hanover 17
Biên Hòa 16
San Nicola Manfredi 16
Belo Horizonte 15
Redmond 15
Troina 15
Baghdad 14
Orem 14
Columbus 13
Curitiba 13
Lima 13
Olomouc 13
Salvador 13
Thái Bình 13
Tokyo 13
Dhaka 12
Guayaquil 12
Ankara 11
Dublin 11
Hải Dương 11
Ninh Bình 11
Shenzhen 11
Tashkent 11
Bologna 10
Paris 10
Amsterdam 9
Asunción 9
Campinas 9
Chennai 9
Pune 9
Taipei 9
Toronto 9
Brasília 8
Cairo 8
Frankfurt am Main 8
Guarulhos 8
Johannesburg 8
Manchester 8
New Delhi 8
Osasco 8
Porto Alegre 8
Santo Domingo 8
Wuhan 8
Augusta 7
Bauru 7
Cape Town 7
Falls Church 7
Goiânia 7
Istanbul 7
Totale 7.717
Salva come PNG Salva come JPEG
Nome #
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-independent and associated with an increase of CD25(+) cells 134
Arg16Gly 132-Adrenoreceptor Polymorphism in Severe Eosinophilic Asthma: Implications for Mepolizumab Long-Term Effectiveness and Clinical Remission 101
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 100
Ruolo dei calcio-antagonisti nella prevenzione e nel trattamento dell’asma bronchiale 93
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 92
Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-α and Haemophilus influenzae in human bronchial epithelial cells 89
High-flow nasal oxygen therapy in intensive care and anaesthesia 86
Endothelin-1 induces proliferation of human lung fibroblasts and IL-11 secretion through an ET(A) receptor-dependent activation of MAP kinases 86
Application of proteomics and peptidomics to COPD 84
High-flow nasal cannula oxygen therapy for outpatients undergoing flexible bronchoscopy: a randomised controlled trial 83
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 82
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 79
Type 2 severe asthma: pathophysiology and treatment with biologics 77
A case of Hughes-Stovin sindrome associated with Budd-Chiari sindrome 77
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma 76
Adverse drug reactions to antibiotics observed in two pulmonology divisions of Catanzaro, Italy: A six-year retrospective study 74
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 73
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study 72
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 72
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 71
Is the mitochondrial benzodiazepine receptor involved in the control of airway smooth muscle tone? 70
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy 70
Asthma and COPD proteomics: Current approaches and future directions 70
Peptidomic analysis of induced sputum of asthmatic patients by MSB-MALDI-TOF-MS platform 70
A case of Hughes-Stovin syndrome associated with Budd-Chiari syndrome 70
Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts 70
Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach 70
A single-blind comparative study of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 69
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 69
Alpha-interferon and its effects on signal transduction pathways 68
A single-blind, partial crossover clinical trial of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 68
The sodium-phosphate co-transporter SLC34A2, and pulmonary alveolar microlithiasis: presentation of an inbred family and a novel truncating mutation in exon 3 67
A case of alveolar proteinosis associated with pulmonary nocardiosis 66
Objective and self-evaluation voice analysis after transoral laser cordectomy and radiotherapy in T1a-T1b glottic cancer 66
An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD 65
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases 65
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 64
Asthma management in a specialist setting: results of an Italian Respiratory Society survey 64
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 64
Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments 63
Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations 63
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 62
Effects of Ambrisentan in a Patient Affected by Combined Pulmonary Fibrosis and Emphysema and by Severe Pulmonary Hypertension: Clinical, Functional, and Biomolecular Findings 62
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non small lung cancer cells. 62
Application of MSB-MALDI-TOF-MS Technology to body fluids and Tissues peptidome profiling 62
LEBRIKIZUMAB Anti-interleukin-13 monoclonal antibody, Treatment of asthma 62
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose 62
A rare case of infection of the lower respiratory tract caused by Bordetella bronchiseptica 61
Airways smooth muscle response to biological stimuli 60
Adverse drug reactions in hospitalized patients following antibiotics administration 60
Molecular mechanisms underlying airway smooth muscle contraction and proliferation: Implications for asthma 60
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 60
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets 59
Emerging biological treatments for asthma 59
Anticolinergici 59
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 58
Benralizumab:from the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 58
Kartagener's syndrome in a woman with a normal ciliary structure and an intracranial meningioma 58
Valutazione in doppio cieco dell’effetto broncodilatante del procaterolo somministrato per aerosol dosato 58
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide 57
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial 57
Adverse drug reactions in hospitalized patients following bronchodilators administration 56
Adverse drug reactions in hospitalized patients following NSAIDs administration 55
Adverse drug reaction in two pneumology units of Catanzaro 55
Effects of MAPK inhibitors on H2O2-induced IL-8 production and cell death in primary cultures of human bronchial epithelial cells 55
Use of narrative medicine to identify key factors for effective doctor-patient relationships in severe asthma 55
Oxygenation strategies during flexible bronchoscopy: a review of the literature 55
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 55
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 55
Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury 55
Role of biologics in severe eosinophilic asthma - focus on reslizumab 54
Agonisti beta2-adrenergici 54
Early management of COPD: where are we now and where do we go from here? 54
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma 54
Effects of glucocorticoids on activation of c-jun N-terminal, extracellular signal-regulated, and p38 MAP kinases in human pulmonary endothelial cells 53
Nitric oxide in upper airways inflammatory diseases 53
Effects of transforming growth factor-beta and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells 53
Effects of simvastatin and rosuvastatin on RAS protein, matrix metalloproteinases and NF-kappa B in lung cancer and in normal pulmonary tissues 53
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 53
Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence. 53
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 52
STRUCTURE OF THE RAT GENE ENCODING THE MITOCHONDRIAL BENZODIAZEPINE RECEPTOR 52
P38 signalling pathway in primary cultures of human bronchial epithelial cells: effects of transforming growth factor-β and pharmacological modulation by budesonide 52
An insight into pharmacological and clinical basis of anti-IgE for add-on therapy of severe asthma 52
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-indipendent and associated with an increase of CD25+ cells 52
Inhibitory effects of the IL-6 receptor superantagonist SANT7 on MAP kinase phosphorylation and cell proliferation induced by IL-6 and TGF-beta1in human lung fibroblasts 52
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 52
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma 52
Effects of transforming growth factor-β and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells 52
Real-world experience with benralizumab in patients with severe eosinophilic asthma: A case series 52
Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases 51
T CELL ACTIVATION STATE IN THE INDUCED SPUTUM OF ASTHMATICS TREATED WITH BUDESONIDE 51
Basi fisiopatologiche della terapia del broncospasmo 51
Phenotyping severe asthma: a rationale for biologic therapy 51
Predictors of renal function worsening in patients with chronic obstructive pulmonary disease (Copd): A multicenter observational study 51
Pre-biologic FeNO might predict anti-IL-5/IL-5Rα response to treatment in severe asthmatics 50
Real-Life Effects of Omalizumab on Chronic Rhinosinusitis with Nasal Polyposis 50
The severe asthma network in Italy: findings and perspectives 50
Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry. 50
Retrospective analysis of adverse drug reactions induced by gemcitabine treatment in patients with non-small cell lung cancer 50
Totale 6.363
Salva come PNG Salva come JPEG
Categoria #
all - tutte 130.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 130.930
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022580 0 5 19 111 46 18 31 141 53 57 89 10
2022/20231.692 465 65 66 127 182 169 16 116 276 78 110 22
2023/2024686 143 90 59 37 36 169 14 24 8 27 24 55
2024/20252.718 412 137 97 105 194 344 93 75 348 144 280 489
2025/20266.723 325 754 762 1.269 643 274 806 369 857 413 173 78
2026/2027442 83 359 0 0 0 0 0 0 0 0 0 0
Totale 13.304